- Home
- News
Talc in the news
From time to time, the topic of talc will be in the news. This is the Johnson & Johnson home for company statements on major news events related to talc.
Johnson & Johnson Statement on Bynum Case Dismissal
January 30, 2026 - Attributable to Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson: “We applaud the trial court for its clear and decisive ruling rejecting the baseless medical monitoring claim. Plaintiff lawyers once again tried to manufacture a frivolous theory of liability, and the Court correctly refused to endorse it. This decision reinforces that meritless pleadings designed to pressure defendants into coercive settlements have no place in our courts.”
Johnson & Johnson Statement on Love Case Dismissal
January 29, 2026 – Attributable to Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson: “The Judge correctly rejected as wholly meritless claims contrived by the plaintiff lawyers in a failed effort to convert a proper divestiture into a fraudulent conveyance.”
Special Master Excludes Key Plaintiffs’ Expert Opinions in Talc Daubert Recommendation
Special Master erroneously allowed certain other plaintiffs’ expert opinions - reiterating the same flawed reasoning from her 2020 decision, disregarding changes to the Federal Rules of Evidence Company will promptly appeal to the District Court the erroneous aspects of the recommendation, which has no legal import until that appeal is resolved Recommendation only reinforces the Company’s overall litigation strategy
Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
Company has prevailed in 16 of 17 ovarian cases tried in the last 11 years Company will reverse approximately $7 billion from amounts previously reserved for the bankruptcy resolution